Methanone, (4-chlorophenyl)[4-(8-nitro-5-quinolinyl)-1-piperazinyl]-, 97%, 100mg

(S)-2-(2-Oxopyrrolidin-1-yl)butanamide, 95.0%, 25g

2-Bromo-4-methylphenol, 95.0%, 250g

2,6-Difluoropyridine, 98.0%, 1g

2-(2-Methoxyethyl)-1-methylpiperidine, 1g

3-Bromo-2,6-dimethylpyridine, 95.0%, 10g

Fermeture double paroi PP noir RD 18

(S)-2-((S)-2-Amino-3-phenylpropanamido)-5-guanidino-N-(naphthalen-2-yl)pentanamide dihydrochloride, 99%, 10mg

7-Bromo-2-chloro-4-methylquinoline, 95%, 1g

1-Boc-4-Fluoro-4-(hydroxymethyl)piperidine, 95.0%, 1g

2-AZASPIRO[4.4]NONANE-2-CARBOXYLIC ACID, 7-HYDROXY-, 1,1-DIMETHYLETHYL ESTER, 95.0%, 100mg

Ethyl 2-cyanoisonicotinate, 95.0%, 5g

2-(1-(((9H-Fluoren-9-yl)methoxy)carbonyl)piperidin-4-yl)acetic acid, 95.0%, 5g